4 months ago
ARWR
AnalystsJason GerberryJason Gerberry's Stock Forecasts
AnalystsJason Gerberry
Analyst Ranking
Top 17%
#746 out of 4565 analysts
Average Return
+6.43%
Win Rate
48%39 out of 82
Risk vs Reward
Poor
Good
Jason Gerberry's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd CoHZNP | +246.56% | $24.87 | $86.19 | 2020-03-23 - 2021-03-23 | Strong Buy |
Bioverativ IncBIVV | +134.78% | $44.10 | $103.54 | 2017-02-15 - 2018-02-15 | Buy |
Jazz Pharmaceuticals PLCJAZZ | +87.27% | $87.74 | $164.31 | 2020-03-23 - 2021-03-23 | Strong Buy |
Beyondspring IncBYSI | +87.16% | $4.44 | $0.57 | 2021-12-02 - 2022-12-01 | Sell |
Cara Therapeutics IncCARA | +84.27% | $4.45 | $0.70 | 2023-05-16 - 2024-04-25 | Sell |
Jason Gerberry Analyst Color
Get additional color on Jason Gerberry's coverage of popular stocks
4 months ago
PCVX
4 months ago
XENE
4 months ago
BLUE
4 months ago
IMVT
5 months ago
BLUE
7 months ago
LYRA
8 months ago
TEVA
9 months ago
JAZZ
9 months ago
BLUE
a year ago
IMVT
a year ago
ACLX
a year ago
PCVX
a year ago
FGEN
2 years ago
XENE
2 years ago
KRTX
Jason Gerberry's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $91.00 | +26.16% | Maintains | 10 days ago |
Galapagos NvGLPG | 5 | Sell | $31.00 | +8.28% | Downgrades | a month ago |
Lyra Therapeutics IncLYRA | 3 | Strong Buy | $11.00 | +112.77% | Maintains | a month ago |
Catalyst Pharmaceuticals IncCPRX | 1 | Strong Buy | $23.00 | +56.68% | Initiates Coverage On | 2 months ago |
Alkermes PLCALKS | 5 | Hold | $29.00 | +18.66% | Maintains | 4 months ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $37.00 | +69.18% | Maintains | 4 months ago |
Vaxcyte IncPCVX | 2 | Strong Buy | $80.00 | +33.20% | Maintains | 4 months ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $56.00 | +39.65% | Maintains | 4 months ago |
Prokidney CorpPROK | 1 | Hold | $2.00 | -26.20% | Downgrades | 4 months ago |
Ionis Pharmaceuticals IncIONS | 3 | Strong Buy | $62.00 | +48.18% | Upgrades | 4 months ago |
Harmony Biosciences Holdings IncHRMY | 2 | Sell | $30.00 | +3.70% | Downgrades | 4 months ago |
Bluebird Bio IncBLUE | 6 | Strong Buy | $5.00 | +448.25% | Maintains | 4 months ago |
Immunovant IncIMVT | 3 | Strong Buy | $51.00 | +83.78% | Maintains | 4 months ago |
Amphastar Pharmaceuticals IncAMPH | 1 | Hold | $63.00 | +54.30% | Initiates Coverage On | 5 months ago |
Viatris IncVTRS | 2 | Sell | $9.00 | -21.53% | Downgrades | 6 months ago |
Teva Pharmaceutical Industries LtdTEVA | 7 | Strong Buy | $13.00 | -1.89% | Maintains | 8 months ago |
Karuna Therapeutics IncKRTX | 2 | Strong Buy | $259.00 | -21.47% | Maintains | 8 months ago |
Oculis Holding AgOCS | 2 | Strong Buy | $24.00 | +100.84% | Maintains | 8 months ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $217.00 | +101.99% | Maintains | 9 months ago |
Fibrogen IncFGEN | 6 | Sell | $2.00 | +96.08% | Downgrades | 9 months ago |
Axsome Therapeutics IncAXSM | 2 | Hold | $81.00 | +13.26% | Upgrades | 9 months ago |
Cara Therapeutics IncCARA | 2 | Sell | $4.00 | +471.43% | Maintains | a year ago |
Arcellx IncACLX | 3 | Strong Buy | $50.00 | -2.69% | Maintains | a year ago |
Applied Molecular Transport IncAMTI | 2 | Sell | $0.50 | N/A | Downgrades | a year ago |
Allogene Therapeutics IncALLO | 1 | Sell | $9.00 | N/A | Downgrades | a year ago |
Organon & CoOGN | 3 | Sell | $25.00 | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 3 | Hold | $141.00 | N/A | Upgrades | 2 years ago |
Beyondspring IncBYSI | 2 | Sell | $5.00 | N/A | Downgrades | 2 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | 3 years ago |
Finch Therapeutics Group IncFNCH | 1 | Strong Buy | $750.00 | N/A | Initiates Coverage On | 3 years ago |
Bausch Health Companies IncBHC | 2 | Sell | $27.00 | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Sell | $9.00 | N/A | Downgrades | 4 years ago |
Coherus Biosciences IncCHRS | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Verrica Pharmaceuticals IncVRCA | 1 | Hold | $10.00 | N/A | Downgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $92.00 | N/A | Initiates Coverage On | 4 years ago |
Eli Lilly & CoLLY | 4 | Strong Buy | $180.00 | N/A | Maintains | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $56.00 | N/A | Upgrades | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $42.00 | N/A | Maintains | 4 years ago |
Pfizer IncPFE | 2 | Strong Buy | $48.00 | N/A | Maintains | 5 years ago |
Bristol Myers Squibb CoBMY | 4 | Hold | $51.00 | N/A | Maintains | 5 years ago |
Foamix Pharmaceuticals LtdFOMX | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 5 years ago |
Abbvie IncABBV | 3 | Strong Buy | $106.00 | N/A | Maintains | 6 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Strong Buy | $1,250.00 | N/A | Maintains | 6 years ago |
Merck & Co IncMRK | 3 | Strong Buy | $74.00 | N/A | Maintains | 6 years ago |
Allergan PLCAGN | 3 | Strong Buy | $213.00 | N/A | Maintains | 6 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Bioverativ IncBIVV | 1 | Buy | $56.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.